Latest Insider Transactions at Relmada Therapeutics, Inc. (RLMD)
This section provides a real-time view of insider transactions for Relmada Therapeutics, Inc. (RLMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RELMADA THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RELMADA THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 22
2024
|
Charles J Casamento Director |
SELL
Bona fide gift
|
Direct |
13,000
-100.0%
|
-
|
|
Sep 11
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
24,120
+21.45%
|
$48,240
$2.95 P/Share
|
|
Sep 11
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
51,407
+11.81%
|
$102,814
$2.99 P/Share
|
|
Sep 10
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
21,118
+24.75%
|
$42,236
$2.73 P/Share
|
|
Sep 10
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
33,014
+9.03%
|
$66,028
$2.75 P/Share
|
|
Sep 09
2024
|
Paul Edward Kelly Director |
BUY
Open market or private purchase
|
Direct |
25,000
+10.54%
|
$50,000
$2.59 P/Share
|
|
Sep 09
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
8,194
+15.98%
|
$16,388
$2.55 P/Share
|
|
Sep 09
2024
|
Charles J Casamento Director |
BUY
Open market or private purchase
|
Direct |
13,000
+50.0%
|
$26,000
$2.56 P/Share
|
|
Sep 09
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
55,579
+15.65%
|
$111,158
$2.71 P/Share
|
|
Jan 31
2024
|
Chuck Ence CA and CO |
BUY
Open market or private purchase
|
Direct |
13,670
+25.97%
|
$54,680
$4.05 P/Share
|
|
Jan 31
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
6,875
+16.46%
|
$27,500
$4.06 P/Share
|
|
Jan 31
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,460
+10.11%
|
$109,840
$4.0 P/Share
|
|
Jan 30
2024
|
Chuck Ence CA and CO |
BUY
Open market or private purchase
|
Direct |
14,500
+36.43%
|
$43,500
$3.87 P/Share
|
|
Jan 30
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+34.86%
|
$45,000
$3.89 P/Share
|
|
Jan 30
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
40,999
+15.92%
|
$122,997
$3.9 P/Share
|
|
Jan 29
2024
|
Chuck Ence CA and CO |
BUY
Open market or private purchase
|
Direct |
10,800
+50.0%
|
$32,400
$3.65 P/Share
|
|
Jan 29
2024
|
Maged Shenouda Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,800
+45.32%
|
$32,400
$3.65 P/Share
|
|
Jan 29
2024
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
31,541
+15.23%
|
$94,623
$3.71 P/Share
|
|
May 23
2023
|
Cedric O'Gorman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+49.7%
|
$30,000
$3.18 P/Share
|
|
Dec 08
2022
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
55,250
+27.73%
|
$110,500
$2.1 P/Share
|
|
Jul 01
2022
|
Sergio Traversa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,755
-4.63%
|
$247,590
$18.42 P/Share
|
|
Jul 01
2022
|
Sergio Traversa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,755
+11.83%
|
$220,080
$16.0 P/Share
|
|
Jun 30
2022
|
Sergio Traversa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,012
-7.91%
|
$304,228
$19.19 P/Share
|
|
Jun 30
2022
|
Sergio Traversa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,012
+13.26%
|
$256,192
$16.0 P/Share
|
|
Apr 04
2022
|
Paul Edward Kelly Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.07%
|
$300,000
$30.04 P/Share
|
|
Apr 04
2022
|
Paul Edward Kelly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.82%
|
$30,000
$3.24 P/Share
|
|
Apr 01
2022
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
19,800
-40.83%
|
$574,200
$29.0 P/Share
|
|
Apr 01
2022
|
Charles J Casamento Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,800
+50.0%
|
$59,400
$3.24 P/Share
|
|
Jan 03
2022
|
Paul Edward Kelly Director |
SELL
Exercise of conversion of derivative security
|
Direct |
20,000
-9.65%
|
$60,000
$3.24 P/Share
|
|
Sep 22
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
6,600
-15.39%
|
$191,400
$29.0 P/Share
|
|
Sep 22
2021
|
Charles J Casamento Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.59%
|
$40,000
$4.6 P/Share
|
|
Aug 17
2021
|
Charles J Casamento Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+40.49%
|
$40,000
$4.6 P/Share
|
|
Jul 15
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,300
-23.29%
|
$102,300
$31.76 P/Share
|
|
Jun 01
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-15.76%
|
$99,000
$33.64 P/Share
|
|
May 03
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-23.17%
|
$114,000
$38.22 P/Share
|
|
Apr 01
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-9.88%
|
$105,000
$35.49 P/Share
|
|
Mar 10
2021
|
Sergio Traversa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,983
-3.25%
|
$104,405
$35.09 P/Share
|
|
Mar 10
2021
|
Maged Shenouda Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,373
-51.58%
|
$83,055
$35.11 P/Share
|
|
Mar 09
2021
|
Paul Edward Kelly Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.46%
|
$175,000
$35.88 P/Share
|
|
Mar 09
2021
|
Paul Edward Kelly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.82%
|
$15,000
$3.24 P/Share
|
|
Mar 09
2021
|
Sergio Traversa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,017
-3.59%
|
$245,595
$35.87 P/Share
|
|
Mar 09
2021
|
Sergio Traversa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.19%
|
$30,000
$3.24 P/Share
|
|
Mar 09
2021
|
Maged Shenouda Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,527
-37.67%
|
$263,445
$35.72 P/Share
|
|
Mar 08
2021
|
Maged Shenouda Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.82%
|
$3,500
$35.0 P/Share
|
|
Mar 08
2021
|
Maged Shenouda Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.99%
|
$30,000
$3.24 P/Share
|
|
Mar 01
2021
|
Charles J Casamento Director |
SELL
Open market or private sale
|
Direct |
3,000
-15.83%
|
$99,000
$33.87 P/Share
|
|
Feb 24
2021
|
Maged Shenouda Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-34.6%
|
$102,000
$34.21 P/Share
|
|
Feb 24
2021
|
Maged Shenouda Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+36.46%
|
$9,000
$3.24 P/Share
|
|
Feb 24
2021
|
Paul Edward Kelly Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.97%
|
$170,000
$34.63 P/Share
|
|
Feb 24
2021
|
Paul Edward Kelly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.82%
|
$15,000
$3.24 P/Share
|